A patient with hepatic cirrhosis (Child-Pugh C) requires analgesic dosing adjustment. Which opioid requires the LEAST dose modification due to minimal hepatic first-pass metabolism and primary renal excretion?

• A Codeine (requires hepatic CYP2D6 to convert to morphine; impaired in cirrhosis)
• B Hydromorphone (extensive hepatic glucuronidation affected by cirrhosis)
• C Morphine (though active metabolite M6G accumulates in renal/hepatic failure) ✓
• D Tramadol (extensive CYP2D6 and CYP3A4 hepatic metabolism severely impaired in cirrhosis)

Explanation

Morphine undergoes extensive hepatic first-pass glucuronidation to morphine-6-glucuronide (M6G, active analgesic) and morphine-3-glucuronide (M3G, neuroexcitatory). In cirrhosis, reduced first-pass reduces M6G production but the unchanged morphine reaching systemic circulation increases. M6G then accumulates in renal failure. Despite these complexities, morphine dose adjustment is more predictable than codeine (which requires CYP2D6 bioactivation entirely abolished in severe liver disease) or tramadol (heavily CYP-dependent for active metabolite production).

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.